Amritomed Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2023.
2023 Delhi, Delhi, India Active
Last Updated:
Access Report
About Amritomed Pharmaceutical Private Limited

Amritomed Pharmaceutical Private Limited, a active private limited company, was established on 20 January 2023 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909DL2023PTC410222. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Kumari Sarita (Director), Ashutosh Kumar Jha (Director). Past directors included Mahesh Kumar. It is based at H.N 54&55, Gali No. 5, Block E Vikas Nag Ar, Uttamnagar Near Shikha Deep School, Delhi, Delhi, 110059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2023PTC410222

  • Registration Number

    410222

  • Incorporation Date

    20 January 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 1 Month
Company report

Amritomed Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Amritomed Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Amritomed Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Kumari Sarita Director 20 Jan 2023 Current
Ashutosh Kumar Jha Director 06 Jun 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Jun 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Amritomed Pharmaceutical.

Enhance accessibility to Amritomed Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Amritomed Pharmaceutical revenue growth over time
Amritomed Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Amritomed Pharmaceutical?

Unlock access to Amritomed Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Amritomed Pharmaceutical?

Amritomed Pharmaceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Amritomed Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amritomed Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Amritomed Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Ashutosh Kumar Jha was appointed as a Director was appointed as a Director on 06 Jun 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Kumari Sarita was appointed as a Director was appointed as a Director on 20 Jan 2023 & has been associated with this company since 3 years 1 month . was completed.

  • Company Incorporation

    The activity Amritomed Pharmaceutical Private Limited was registered on 20 Jan 2023 with Roc Delhi I & aged 3 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Amritomed Pharmaceutical Private Limited?

The CIN of Amritomed Pharmaceutical Private Limited is U51909DL2023PTC410222.

Where is Amritomed Pharmaceutical Private Limited headquartered?

Amritomed Pharmaceutical Private Limited is headquartered at H.N 54&55, Gali No. 5, Block E Vikas Nag Ar, Uttamnagar Near Shikha Deep School, Delhi, Delhi, 110059.

When was Amritomed Pharmaceutical Private Limited incorporated?

Amritomed Pharmaceutical Private Limited was incorporated on 20 January 2023.

Who are the current directors of Amritomed Pharmaceutical Private Limited?

The current directors of Amritomed Pharmaceutical Private Limited are

What is the primary industry of Amritomed Pharmaceutical Private Limited?

The primary industry of Amritomed Pharmaceutical Private Limited is Pharma.

Is Amritomed Pharmaceutical Private Limited a listed company?

Amritomed Pharmaceutical Private Limited is unlisted.

What is the capital structure of Amritomed Pharmaceutical Private Limited?

The authorized capital of Amritomed Pharmaceutical Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Amritomed Pharmaceutical Private Limited?

The compliance status of Amritomed Pharmaceutical Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available